- 2022 - 2025 IL-36βの免疫チェックポイント阻害作用による新規肺がん治療法の開発
- 2022 - 2025 Development of pro-inflammatory treatment by cross-sectional control of aging lung metabolism and epigenetics
- 2021 - 2024 新規肺移植後免疫抑制療法の開発を目指した間葉系幹細胞由来の細胞外小胞の解析と応用
- 2021 - 2024 自然免疫とサブタイプに着目した慢性移植肺機能不全のメカニズム解明
- 2021 - 2024 肺葉移植戦略の確立 - 局所二酸化炭素濃度測定による肺葉機能評価 -
- 2020 - 2024 Development of Canada-Japan joint novel an Ex Vivo Lung Perfusion System
- 2016 - 2019 Elucidation of pathophysiology of chronic rejection after lung transplantation and development of a novel therapeutic method through IL-17 pathway.
- 2015 - 2017 Treatment of Lung Ischemia-reperfusion injury by Muse cells
- 2014 - 2016 Investigation of the cell based therapy for primary lung dysfunction after lung transplantation using mesenchymal stem cell
- 2012 - 2015 Prevention of acute and chronic lung allograft rejection by mesenchymal stem cells
Show all